EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity

Jiaqi Ma iD, Cory M Ayres, Chad A Brambley, Bassant Eldaly iD, W W J Gihan Perera iD, James A Lazar iD, Evgenii L Kovrigin, Smita S Chandran, Christopher A Klebanoff, Brian M Baker iD

Proceedings of the National Academy of Sciences · 09.06.2026 · 123 (23)

DOI: 10.1073/pnas.2602949123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 01.06.2026. Verfasst von Jiaqi Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Harper Cancer Research Institute and the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46656. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Polymorphism, Genetic. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell receptor (TCR) restriction by highly polymorphic major histocompatibility complex (MHC) proteins is a foundation of cellular immunity. Although the effects of MHC polymorphisms on peptide binding and selection are well established, how micropolymorphisms within MHC supertypes impact immune recognition is poorly understood. Here, we identified a mechanism through which the micropolymorphisms in two closely related HLA-A3 superfamily members govern TCR specificity. We previously showed that TCRs specific for a public neoantigen arising from a PIK3CA oncogenic hotspot mutation restricted by HLA-A*03:01 were unable to recognize the same epitope in the context of HLA-A*03:02 despite equivalent processing and presentation by both alleles. We found here that the two micropolymorphisms distinguishing A*03:02 from A*03:01 prevent TCR binding not by altering peptide binding or static structures, but by altering the conformational ensemble of the neoantigen, preventing it from adopting a binding-permissive state. The effect is rooted in how the two polymorphic sites interact with other covarying, evolutionarily coupled polymorphisms, reflecting a cross-groove network of interactions that controls the conformational adaptability of the peptide/HLA complex. We suggest polymorphism-dependent adaptability reflects an evolved feature of class I MHC proteins, further diversifying epitopes and contributing to how TCRs and other immunoreceptors differentiate between antigens. Beyond this mechanistic insight, our findings emphasize the need for high-resolution HLA typing in efforts across immunology, including antigen-specific immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, T-CellPolymorphism, GeneticHumansProtein ConformationProtein Binding

Stichwörter der Autor:innen

T cell receptordynamicspeptide/HLAspecificitystructure

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Harper Cancer Research Institute and the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46656.
  • Immuno-Oncology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Center for Cellular Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Weill Cornell Medical College, Department of Medicine, Cornell University, New York, NY 10022.
  • Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY 10065.

ORCID-Profile: Jiaqi Ma, Bassant Eldaly, W W J Gihan Perera, James A Lazar, Brian M Baker

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI)
  • NIGMS NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)

Zitieren

APA

Ma, J., Ayres, C. M., Brambley, C. A., Eldaly, B., Perera, W. W. J. G., Lazar, J. A., Kovrigin, E. L., Chandran, S. S., Klebanoff, C. A., & Baker, B. M. (2026). HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity. Proceedings of the National Academy of Sciences, 123(23). https://doi.org/10.1073/pnas.2602949123

Vancouver

Ma J, Ayres CM, Brambley CA, Eldaly B, Perera WWJG, Lazar JA, et al. HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity. Proceedings of the National Academy of Sciences. 2026;123(23). doi:10.1073/pnas.2602949123

BibTeX
@article{Ma2026,
  author = {Ma, Jiaqi and Ayres, Cory M and Brambley, Chad A and Eldaly, Bassant and Perera, W W J Gihan and Lazar, James A and Kovrigin, Evgenii L and Chandran, Smita S and Klebanoff, Christopher A and Baker, Brian M},
  title = {HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {23},
  doi = {10.1073/pnas.2602949123}
}
Kostenlos starten →